Boehringer ingelheim

Index
Globenewswire

Boehringer Ingelheim Shares Positive Results from the First Study Worldwide in Diabetic Macular Ischemia

Globenewswire

Less than Half of Veterinary Professionals Feel Their Profession is Appreciated

Globenewswire

Boehringer Ingelheim Reports Strong Growth in 2023 and Accelerates Late-stage Pipeline

Globenewswire

SPEVIGO® Approved for Expanded Indications in China and the US

Globenewswire

Survodutide Phase II Trial Shows 83% of Adults Treated Achieved Groundbreaking Results in Liver Disease Due to MASH, with Significant Improvements in Fibrosis

Globenewswire

New Collaboration Between Boehringer Ingelheim and Sleip Leverages AI-technology to help Detect Lameness in Horses

Globenewswire

Boehringer Expands Production Site in Greece for New Medicine